The bean entered the colon carrying carbohydrates and other compounds that human digestion had not absorbed.
Microorganisms do not merely make those materials disappear.
They convert them.
Chemical bonds are broken. Released fragments enter microbial cells. Carbon is rearranged. Electrons and hydrogen are transferred. New molecules leave one organism and become substrates for another.
Some of the resulting compounds were present in neither the dry bean nor the cooked meal.
They exist because the bean encountered the microbiome.
This is the governing principle of the chapter:
Microbial metabolism creates new chemical forms from the bean’s biological potential.
The Bean’s Journey Continues: molecules that were never in the bean
The bean supplied resistant starch, cell-wall carbohydrates, oligosaccharides, residual protein, and associated polyphenols.
Microbial communities transform these substrates through many pathways.
Carbohydrate fermentation can produce short-chain fatty acids, including acetate, propionate, and butyrate. It also produces gases and intermediate compounds used by other organisms. Polyphenol-related structures can be opened, reduced, cleaved, or otherwise converted. Amino acids and host-derived materials enter still other pathways. Bile acids made by the liver can be modified by microbial enzymes.
The resulting mixture contains several kinds of metabolite:
- molecules produced directly from bean-derived substrates;
- molecules produced through cross-feeding among microorganisms;
- host compounds modified by microorganisms after the bean changes the ecological environment; and
- microbial products that are subsequently modified by intestinal cells or the liver.
The word metabolite does not describe one effect.
It describes a molecule formed or altered during metabolism.
To understand its biological meaning, we must know what produced it, where it appeared, how much was present, how long it remained, and which cells encountered it.
Fermentation redirects carbon
When microorganisms use carbohydrate, they must extract energy while maintaining chemical balance inside the cell.
In the oxygen-poor colon, this often occurs through fermentation.
The organism breaks carbohydrate into smaller intermediates, captures some energy, and releases end products. Those products help dispose of carbon and electrons that the microbe cannot use in the same way an oxygen-breathing cell might.
The precise products depend on the organism and pathway.
Some microbes release acetate. Some produce propionate or butyrate. Some produce lactate, succinate, formate, ethanol, hydrogen, or carbon dioxide. A product may accumulate, be absorbed, or become food for another microorganism.
This is why the final metabolite pattern cannot be predicted from the bean alone.
The bean provides substrates.
The community provides pathways.
Acetate, propionate, and butyrate
Acetate, propionate, and butyrate are called short-chain fatty acids because they contain short carbon chains.
They are frequently grouped together, but they are not interchangeable.
They can be produced through different microbial pathways, used differently within the community, transported across the colonic surface, and handled differently after absorption.
Acetate is commonly produced by many colonic microorganisms and can also serve as a substrate for other microbes. A substantial fraction can enter portal and then systemic circulation.
Propionate is produced through several microbial routes. After absorption, much is taken up by the liver, although its fate depends on metabolic conditions.
Butyrate is produced by a more restricted set of pathways and organisms, often through cross-feeding networks. It is used extensively within the colon and splanchnic tissues, so relatively little normally reaches the wider circulation.
Stable-isotope experiments in healthy people demonstrate these different fates. When labeled short-chain fatty acids were delivered to the colon, acetate showed the greatest systemic availability, propionate much less, and butyrate very little. Approximately 98 percent of administered butyrate was extracted before reaching systemic circulation in that experimental setting.[1]
Production in the colon is therefore not the same as exposure throughout the body.
The journey of each metabolite continues after it is made.
Butyrate: one detailed example
Butyrate shows why the pathway from bean to biology must be followed step by step.
The bean does not contain a meaningful store of butyrate waiting to be released.
It contains substrates from which microbial networks may produce butyrate.
A primary degrader can begin opening resistant starch. Other organisms consume the released carbohydrates or intermediate products. Butyrate-producing organisms complete pathways that release butyrate into the colonic environment.
The amount produced depends on:
- the bean substrate that reached the colon;
- its physical accessibility;
- the primary degraders present;
- compatible cross-feeders;
- competition from other pathways;
- colonic pH and transit;
- the supply of nitrogen and other nutrients; and
- how rapidly butyrate is consumed or absorbed.
Once produced, butyrate has several possible destinations.
Other microorganisms may use some. Colonocytes can transport and oxidize it as an energy substrate. Some enters portal blood and is further extracted by the liver and other splanchnic tissues. Only a small fraction generally reaches peripheral circulation.[1]
This explains why fecal butyrate is difficult to interpret.
A low fecal concentration might reflect low production. It might also reflect efficient absorption or use before excretion. A high fecal concentration might reflect high production, reduced absorption, rapid transit, or continued fermentation late in the colon.
The stool contains what remained—not everything that was produced.
Butyrate is important, but it is not the entire microbiome story.
Acetate, propionate, gases, phenolic metabolites, bile-acid transformations, and many other products continue alongside it.
The bean can support short-chain-fatty-acid production
Bean substrates can support microbial production of short-chain fatty acids, but the exact result depends on the bean and the community.
A 2025 laboratory study followed three cooked Chilean common-bean varieties through simulated digestion and fecal fermentation. The bean preparations produced acetate, propionate, and butyrate, while the quantities and accompanying microbial changes differed among varieties.[2]
This experiment demonstrates biochemical possibility under controlled conditions.
It does not tell us exactly how much short-chain fatty acid a person will produce after a meal. The model used fecal communities outside the body and could not reproduce absorption, host secretions, normal spatial organization, or complete colonic transit.
Human interventions add another layer. In a randomized study of pinto beans, bean consumption changed the way participants’ fecal communities fermented test substrates outside the body, but changes in individual short-chain fatty acids were not uniformly in the direction the investigators expected.[3]
This is scientifically useful.
It shows that the claim beans make butyrate is too simple.
A more accurate statement is:
Beans deliver substrates from which microbiomes can produce several metabolites, with outputs determined by the community and conditions.
Polyphenols become different molecules
The bean’s polyphenol story also changes in the colon.
Some polyphenol-related compounds were absorbed earlier. Others reached the colon still attached to the food matrix or in forms poorly absorbed by the small intestine.
Microbial enzymes can remove sugar groups, open rings, split larger structures, reduce double bonds, and create smaller phenolic acids and related compounds.
The molecules that later appear in blood or urine may therefore differ substantially from those measured in the bean.
This has been observed directly in people. After volunteers ate cooked common beans, some metabolites appeared in plasma relatively early, consistent with upper-intestinal absorption and host conjugation. Other metabolites appeared later, consistent with colonic microbial transformation. More than half of several measured metabolites were excreted after eight hours, and responses varied among individuals.[4]
The experiment involved only seven volunteers and one large bean meal, so it should not be treated as a universal metabolic profile.
Its central contribution is stronger than its size:
It demonstrates that human exposure includes transformed bean-related metabolites—not only the native compounds listed in food-composition tables.
The bean’s chemistry continues after the bean disappears.
The microbiome also modifies host molecules
Not every metabolite influenced by a bean-containing meal is made directly from the bean.
Bile acids illustrate this distinction.
The liver makes primary bile acids from cholesterol and releases them into the intestine as part of bile. Most are reabsorbed and returned to the liver. A fraction reaches microorganisms capable of removing conjugated groups and carrying out other transformations, creating a more diverse bile-acid pool.
The bean can influence this process indirectly.
Its fiber and resistant starch alter substrate availability, microbial competition, acidity, transit, and the movement of material through the colon. These ecological changes can affect which microbial bile-acid transformations occur.
But a secondary bile acid is not simply a “bean metabolite.”
It is a host molecule modified through microbial metabolism within an environment that diet helped shape.
Human controlled-feeding studies show that dietary patterns containing whole grains, legumes, fruits, and vegetables can change circulating bile-acid profiles relative to diets rich in refined grains and added sugars. Because those interventions change many foods at once, they cannot assign the effect specifically to beans.[5]
This is precisely why pathways must be named accurately.
Direct transformation and ecological influence are both real, but they are not the same claim.
Protein and nitrogen enter other pathways
Some nitrogen-containing material also reaches the colon—from incompletely digested food, microbial cells, digestive secretions, mucus, and shed host cells.
Microbial metabolism of amino acids can produce branched-chain fatty acids, ammonia, phenols, indoles, sulfur-containing compounds, and many other metabolites.
These products are sometimes described as uniformly harmful, just as short-chain fatty acids are sometimes described as uniformly beneficial.
Neither simplification is adequate.
Biological meaning depends on the molecule, concentration, location, duration, host condition, and the balance of production, microbial use, absorption, and clearance.
A bean meal brings substantial fermentable carbohydrate along with protein. The resulting ecological context differs from delivering isolated protein to a carbohydrate-depleted community.
The whole substrate stream matters.
Production is only the beginning
Once a metabolite is made, several things can happen.
It may:
- remain in the colonic lumen;
- be consumed by another microorganism;
- interact locally with the mucus layer or intestinal surface;
- cross into a colonocyte;
- be used as fuel within that cell;
- enter portal blood;
- be transformed or extracted by the liver;
- reach systemic circulation;
- be filtered or secreted into urine;
- return to the intestine through bile; or
- leave in stool or gas.
The concentration measured at any one location is the net result of these processes.
This can be expressed simply:
Measured concentration = production − microbial use − host uptake − transformation − clearance, modified by movement and time
The equation is conceptual rather than mathematical, but it prevents a common error.
A metabolite level is not a direct reading of microbial production.
It is a snapshot of a moving system.
Location changes meaning
A molecule can have different biological opportunities depending on where it appears.
Butyrate at the surface of a colonocyte is positioned for local transport and metabolism. Butyrate reaching portal blood encounters the liver before the wider circulation. Acetate that passes through the liver may become available to peripheral tissues. A phenolic metabolite in urine documents exposure and clearance but not necessarily prolonged activity in a target tissue.
Concentration matters as well.
A compound may change a cultured cell at a concentration never reached after eating beans. A metabolite may act locally in the colon at a concentration much higher than occurs in peripheral blood. A brief post-meal exposure differs from continuous experimental treatment.
This is where many attractive food claims fail.
The molecule exists. The mechanism is plausible. But the tested concentration, chemical form, cell type, or location does not match human exposure.
The Bean’s Journey requires those details.
The Bean’s Journey: microbial products move forward
The bean has now crossed another boundary.
It began as a plant structure. Digestion divided it into absorbed nutrients and a colonic stream. The microbiome used that stream as an ecological resource.
Now new molecules extend the pathway.
Acetate, propionate, and butyrate emerge from carbohydrate fermentation. Gases reflect microbial redox balance and cross-feeding. Polyphenol-related structures become smaller and chemically different metabolites. Host bile acids are modified within the microbial environment. Nitrogen-containing substrates enter additional pathways.
Some products remain local. Some enter the host. Some are transformed again before any distant tissue encounters them.
The original bean is gone.
Its transformed carbon and chemical influence remain in motion.
What the evidence can establish at this stage
Laboratory fermentation can show that a microbial community produces particular metabolites from digested bean material. Isotope tracing can establish the origin and fate of a molecule. Portal or peripheral blood measurements can quantify exposure. Urine and stool can reveal metabolites that were cleared or remained. Human feeding studies can test whether eating beans changes those measurements.
Each result answers a bounded question.
Finding butyrate in a fermentation vessel demonstrates production under those conditions. Finding a bean-related phenolic metabolite in urine demonstrates that transformation and exposure occurred. A change in a circulating bile acid after a dietary pattern does not prove that beans caused it. A metabolite associated with health in an observational study does not establish that increasing it will improve health.
The pathway has advanced from substrate to product:
Food → Digestion → Microbiome → Metabolites
The next question is not whether the metabolites exist.
It is whether cells can detect and respond to them at realistic exposures.
The Bean at This Stage
The bean has become a changing field of microbial products.
Some are abundant in the colon but scarce in systemic blood. Some are used almost as soon as they are produced. Some reach the liver. Some travel farther. Some appear only briefly. Some leave measurable traces in urine, stool, or breath.
No single metabolite represents the entire bean.
The mixture reflects the prepared food, human digestion, microbial community, host physiology, location, and time.
These molecules now approach cells equipped with transporters, receptors, enzymes, and signaling systems.
Production has created the exposure.
Cellular sensing will determine whether and how cells detect and respond to that exposure.
Next — Cellular Sensing: How Cells Detect the Journey
The next chapter follows bean-derived nutrients and microbial metabolites to the cells that encounter them.
How does a colonocyte detect butyrate? How does an intestinal endocrine cell respond to nutrients or microbial products? What reaches the liver through portal blood? Which molecules enter cells, and which act at the surface?
A metabolite becomes biologically meaningful only when it enters a system capable of sensing or using it.
The journey now moves from microbial chemistry to cellular response.
Notes and selected references
- Boets E, Gomand SV, Deroover L, et al. Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study. Journal of Physiology. 2017;595(2):541–555. doi:10.1113/JP272613.
- Nina N, Bressa C, de Lucas B, et al. Polyphenol metabolism, short-chain fatty acids production, and microbiota changes during in vitro digestion and fermentation of Chilean beans (Phaseolus vulgaris L.). Food Chemistry. 2025;486:144669. doi:10.1016/j.foodchem.2025.144669.
- Finley JW, Burrell JB, Reeves PG. Pinto bean consumption changes SCFA profiles in fecal fermentations, bacterial populations of the lower bowel, and lipid profiles in blood of humans. Journal of Nutrition. 2007;137(11):2391–2398. doi:10.1093/jn/137.11.2391.
- Mecha E, Feliciano RP, Rodriguez-Mateos A, et al. Human bioavailability of phenolic compounds found in common beans: the use of high-resolution MS to evaluate inter-individual variability. British Journal of Nutrition. 2020;123(3):273–292. doi:10.1017/S0007114519002836.
- Ginos BNR, Navarro SL, Schwarz Y, et al. Circulating bile acids in healthy adults respond differently to a dietary pattern characterized by whole grains, legumes and fruits and vegetables compared to a diet high in refined grains and added sugars: a randomized, controlled, crossover feeding study. Metabolism. 2018;83:197–204. doi:10.1016/j.metabol.2018.02.006.